Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART-GUIDE-HBR: Genotype-Guided vs Un-Guided DAPT in ACS
NCT06763744Phase 4Not yet recruiting
- Sponsor
- Samsung Medical Center
- Start
- Jun 2025
- Primary completion
- Jul 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in acute coronary syndrome (ACS), sponsored by Samsung Medical Center. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
clopidogrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT06763744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06763744.